Review |
Recent trends and important developments in propolis research
Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences 1113 Sofia, Bulgaria
The newest developments in propolis pharmacological research are summarized. The problem regarding biological studies, caused by the chemical variability of propolis, is discussed. The most important trends and developments in recent propolis research are outlined: biological studies performed with chemically characterized samples, bioassay-guided studies of active principles and comparative biological studies of propolis of different origin and chemical composition. These types of studies are extremely valuable with respect to propolis standardization and practical applications in therapy. They will allow scientists to connect a particular chemical propolis type to a specific type of biological activity and formulate recommendations for practitioners.
Keywords: propolis – plant origin – bioactive compounds – composition/activity relationship
For reprints and all correspondence: Vassaya Bankova, Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria. Tel: +359-2-9606-149; Fax: +359-2-8700-225; E-mail: bankova{at}orgchm.bas.bg
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. C. Bufalo, J. M. G. Candeias, and J. M. Sforcin In vitro Cytotoxic Effect of Brazilian Green Propolis on Human Laryngeal Epidermoid Carcinoma (HEp-2) Cells Evid. Based Complement. Altern. Med., December 1, 2009; 6(4): 483 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kunimasa, M.-R. Ahn, T. Kobayashi, R. Eguchi, S. Kumazawa, Y. Fujimori, T. Nakano, T. Nakayama, K. Kaji, and T. Ohta Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-forming Endothelial Cells through Inactivation of Survival Signal ERK1/2 Evid. Based Complement. Altern. Med., April 7, 2009; (2009) nep024v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hellner, D. Winter, R. von Georgi, and K. Munstedt Apitherapy: Usage And Experience In German Beekeepers Evid. Based Complement. Altern. Med., December 1, 2008; 5(4): 475 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Senedese, A. R. Rodrigues, M. A. Furtado, V. D. Faustino, A. A. Berretta, J. M. Marchetti, and D. C. Tavares Assessment of the Mutagenic Activity of Extracts of Brazilian Propolis in Topical Pharmaceutical Formulations on Mammalian Cells In Vitro and In Vivo Evid. Based Complement. Altern. Med., July 9, 2008; (2008) nen049v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Teixeira, D. Message, G. Negri, A. Salatino, and P. C. Stringheta Seasonal Variation, Chemical Composition and Antioxidant activity of Brazilian Propolis Samples Evid. Based Complement. Altern. Med., January 31, 2008; (2008) nem177v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper Colony Collapse Disorder May Affect Complementary and Alternative Medicine Evid. Based Complement. Altern. Med., September 1, 2007; 4(3): 275 - 277. [Full Text] [PDF]
|
|
|
|
|
|
B. Trusheva, M. Popova, V. Bankova, S. Simova, M. C. Marcucci, P. L. Miorin, F. d. R. Pasin, and I. Tsvetkova Bioactive Constituents of Brazilian Red Propolis Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper eCAM benefits from diversity that derives from CAM Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 263 - 265. [Full Text] [PDF]
|
|